Astra Space, Inc. - Class A Common Stock (ASTR)

Revenue doubled year-over-year as Scorpio X-Series enters volume production.

Vanguard's ultra-low 0.05% fee trails iShares' 33.7% one-year gain, forcing investors to weigh long-term savings against recent outperformance.

AMD's Helios rack-scale AI systems are set to ramp this quarter, benefiting ecosystem partners Broadcom, Hewlett Packard Enterprise, Astera Labs, and Core Scientific, per analyst ratings and price targets.

One operates at the bleeding edge of AI infrastructure; the other owns the architectural blueprint powering global computing.

This ETF outperforms its benchmarks and large-cap growth ETFs.

Astera Labs beat Q2 estimates with 104.5% revenue growth and raised guidance, driven by its Scorpio product ramp, though shares pulled back despite analysts' rising price targets.

One company builds the hardware that powers AI data centers while the other monetizes the apps that run on them.

Networking stocks like Astera and Arista could be the next big winners as the AI boom continues.

Astera Labs Inc (NASDAQ: ALAB) reported strong Q2 results and raised Q3 guidance, leading to stock price target increases by analysts.

Major U.S. stock indexes finished higher on Tuesday, with the Dow Jones Industrial Average climbing 1.71% to 54,085.88.

Astera Labs (NASDAQ:ALAB) reported record second-quarter revenue and projected a sharp sequential increase for the third quarter, citing accelerating demand for its AI infrastructure connectivity products and the volume-production ramp of its Scorpio X-Series fabric switches. Revenue for the second

Here's a look inside the Q2 earnings report from Astera Labs.

Astera Labs smashed analyst estimates for the second quarter and with its guidance for the current period. ALAB stock rose on the news.

Astera Labs Inc (NASDAQ:ALAB) shares are climbing Monday as investors position ahead of the semiconductor connectivity company's second-quarter earnings report due after Tuesday's close. Here's what you should know.

Russell 1000 fund delivered $1,735 on $1,000 invested over five years, while small-cap alternative returned $1,228 despite lower expense ratio.

One company just doubled its revenue; the other boasts a 39% net margin and robust free cash flow.

A notable customer reported big news yesterday.

Astera Labs is posting triple-digit growth with a fortress balance sheet, while Intel is seeing accelerating data center growth.

One profitable but concentrated, the other scaling fast but burning cash.

One powers AI data centers with explosive growth but customer concentration risk; the other feeds defense spending with steady demand but negative cash flow.

CNBC's Mad Money Lightning Round: Cramer says Astera Labs (ALAB) is a buy, but doesn't care for Rigetti Computing (RGTI). Eli Lilly (LLY) is a classic own, don't trade. MakeMyTrip (MMYT) coverage initiated with Buy rating.

Astera Labs boasts 25% net margins and zero debt, while Nebius scales at triple-digit growth despite heavy infrastructure spending.

One is profitable with fortress balance sheet strength; the other burns cash while chasing quantum breakthroughs.

With expectations sky-high, Astera's Aug. 4 earnings could decide whether the stock's pullback is a bargain or a trap.